Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Guangdong Provincial People's Hospital

5 clinical trials · 5 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Guangdong Provincial People's Hospital

RECRUITINGPhase 2NCT05954897

Lenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular Carcinoma

To evaluate the efficacy and safety of lenvatinib, tislelizumab combined with RALOX regimen HAIC in advanced hepatocellular carcinoma.

Sponsor: Guangdong Provincial People's HospitalEnrolling: 291 location
Hepatocellular Carcinoma
RECRUITINGNCT07154355

Community Exercise Treating Effect on Cardiopulmonary Disease Patients

The goal of this clinical trial is to learn if community-based exercise training can benefit patients aged 18 to 85 with diminished cardiovascular and pulmonary function. The main...

Sponsor: Guangdong Provincial People's HospitalEnrolling: 2001 location
Coronary Heart Disease (CHD)Heart FailureCardiomyopathy+5
RECRUITINGNCT04212455

A Cohort Study on Biomarkers of Hypertension in Guangdong Province(GDP Study)

Hypertension is the most common chronic diseases and a most important risk factor for cardiovascular and cerebrovascular diseases, and also a substantial public health problem....

Sponsor: Guangdong Provincial People's HospitalEnrolling: 500002 locations
HypertensionCardiovascular Diseases
RECRUITINGNCT07495774

Insights Into Pediatric Pulmonary Hypertension: A Real-World Registry of Epidemiology and Outcomes

Pediatric pulmonary hypertension (PH) shares similarities with PH in adulthood, but specific differences still require unique approaches. Despite major advances, risk scores for...

Sponsor: Guangdong Provincial People's HospitalEnrolling: 4501 location
Pulmonary Hypertension
RECRUITINGPhase 1NCT06676631

NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis

This is an investigator-initiated, open-label, single-arm study to determine safety and preliminary efficacy of NK010 or NK042 in combination with rituximab (RTX) for the...

Sponsor: Guangdong Provincial People's HospitalEnrolling: 181 location
Refractory Systemic Lupus ErythematosusRefractory Lupus Nephritis